与2型糖尿病患者的葡萄糖代谢控制相关的阿迪波涅丁和TNFα
Syed Shahid Habib1, Thamir Al-Khlaiwi1, Huthayfah Al-Khliwi1
1Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Journal of family medicine and primary care
|July 29, 2024
概括
在2型糖尿病患者中,阿迪波涅丁水平较低,而TNFα水平较高. 这些发现突出了糖尿病管理和理解疾病进展的潜在生物标志物.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 免疫学 免疫学 免疫学
背景情况:
- 2型糖尿病 (T2DM) 是一种复杂的代谢障碍.
- 阿迪波涅丁和瘤亡因子α (TNFα) 是关键的阿迪波基因,涉及到代谢调节.
- 在T2DM中,这些阿迪波金和葡萄糖代谢参数之间的确切关系需要进一步阐明.
研究的目的:
- 为了研究血清阿迪波涅克和TNFα水平之间的关联.
- 评估它们与T2DM患者的关键葡萄糖代谢参数的相关性.
主要方法:
- 对117名参与者进行了一项横截面研究 (64人患有T2DM,53人健康对照).
- 血清样本被分析为阿迪波内克丁和TNFα度.
- 收集了社会人口统计数据和临床参数.
主要成果:
- 与对照组相比,T2DM组的阿迪波内克水平明显较低 (11.0 ± 4.1 与 14.4 ± 4.3 相比,P=0.000).
- 在T2DM组,TNFα水平明显高于对照组 (7.8 ± 2.7对比6.6 ± 2.9,P=0.024).
- 在T2DM患者中,TNFα与阿迪波内克丁有负相关性,与HbA1c和甘油三有正相关性. 在这两组中,阿迪波涅丁与HDL正相关.
结论:
- 在T2DM患者中,阿迪波内克丁减少,TNFα升高.
- 这些阿迪波金与HDL,HbA1c和甘油三等代谢标记物有明显的相关性.
- 研究结果表明,阿迪波涅丁和TNFα作为T2DM中的生物标志物具有潜在的作用.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Diabetes: Management and Pharmacotherapy
250
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
250
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K


